NEWS & EVENTS
We will be hosting an interim results webinar for Impax Asset Management Group. Ian Simm, Chief Executive, and Charlie Ridge, …READ MORE
The management of Gattaca (AIM:GATC), the leading provider of specialist recruitment services to the Engineering and Technology industries, would like …READ MORE
The management of Ergomed PLC (AIM:ERGO), the company dedicated to the provision of specialised services to the pharmaceutical industry and …READ MORE
$BXP.L further good growth in Q3, to end March: PAT +21% and EPS +22% compared to Q3 '16. Very well run business.
$KMK.L reassuring FY update: good progress on order delivery, expects step change in revenues. Latest ED note here: https://t.co/VNvFTie0HX
Long weekend in UK looming and all quiet at the market opening. Q1 GDP numbers from UK and US may change that. £/$ 1.29 now
$DEMG.L EU grant: €50k re Phase I TruVue, maybe more in future. NB Investor Day, am Fri 5th May: contact email@example.com
$SVCA.L encouraging update on H1 being ahead of internal estimates, Board confident on momentum carrying into H2. Results out 12 June
$IMO.L update 'slightly ahead of ests' - revs +23%, GP + 18%, good cash conversion so £14.7m at y/e. CEO hails strong position and pipeline.
WHY CHOOSE ED
"One of the biggest problems private investors have, is getting access to broker research. It’s basically impossible for many investors. Therefore I feel some commissioned research is really important and a good investment for companies. In my experience ED are far more proactive than other firms in this space."
Blogger and Stockopedia Contributor
"Many thanks to @equity_research for a superb Investor Forum. $BMK.L , $VLG.L & $VP.L all interesting companies. I recommend these events. "
"We cannot thank you enough for opening our eyes to private investors."
"MHP believes commissioned research is an important part of the toolkit to attract new investors and improve liquidity. We rate ED's analysts and research very highly as one of the leading providers in this space."